Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Royal Bank Of Canada's Rating of Abbott Laboratories on 10/22/2026

On October 22, 2026, Royal Bank Of Canada updated its outlook on Abbott Laboratories (NYSE:ABT) with the action "Lower Price Target", setting a price target of $125.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Royal Bank Of Canada

DateCompanyAction
10/26/2026
The Boeing Company stock logo
BA
Boeing
Reiterated Rating
10/26/2026
SGS SA stock logo
SGSOY
SGS
Reiterated Rating
10/26/2026
Holcim Ltd Unsponsored ADR stock logo
HCMLY
Holcim
Reiterated Rating
10/26/2026
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
Downgrade
10/26/2026
CocaCola Company (The) stock logo
KO
CocaCola
Reiterated Rating
10/26/2026
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Boost Price Target
More Ratings From Royal Bank Of Canada